Pfizer says latest COVID-19 vaccine testing shows 95 percent efficiency, emergency use application planned
Pfizer on Wednesday announced that final data on its coronavirus vaccine candidate showed it to be 95 percent effective, adding that the company would be applying for Federal Drug Administration (FDA) emergency authorization “within days.”

Pfizer said that the vaccine candidate, developed with German company BioNTech, is 95 percent effective “against COVID-19 beginning 28 days after the first dose.”
Read the full story here

FDA approves first COVID-19 test kit for home use
The U.S. Food and Drug Administration said on Tuesday it had approved the first COVID-19 self-testing kit for home use that provides results within 30 minutes.

Read in Reuters: https://apple.news/AOcinsMdzTxetBYxmoc6J9g

Shared from Apple News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.